<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peng X</submitter><funding>Adelson Medical Research Foundation</funding><funding>NCI NIH HHS</funding><funding>Natural Scientific Foundation of China</funding><funding>CCSG</funding><funding>NIH</funding><funding>NIH HHS</funding><funding>Cancer Prevention and Research Institute of Texas</funding><funding>MD Anderson Cancer Center</funding><funding>Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine</funding><pagination>817-828.e7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5953833</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(5)</volume><pubmed_abstract>Adenosine (A) to inosine (I) RNA editing introduces many nucleotide changes in cancer transcriptomes. However, due to the complexity of post-transcriptional regulation, the contribution of RNA editing to proteomic diversity in human cancers remains unclear. Here, we performed an integrated analysis of TCGA genomic data and CPTAC proteomic data. Despite limited site diversity, we demonstrate that A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences. We validate the presence of editing events at both RNA and protein levels. The edited COPA protein increases proliferation, migration, and invasion of cancer cells in vitro. Our study suggests an important contribution of A-to-I RNA editing to protein diversity in cancer and highlights it</pubmed_abstract><journal>Cancer cell</journal><pubmed_title>A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.</pubmed_title><pmcid>PMC5953833</pmcid><funding_grant_id>CA175486</funding_grant_id><funding_grant_id>P50 CA098258</funding_grant_id><funding_grant_id>S10 OD012304</funding_grant_id><funding_grant_id>CA209851</funding_grant_id><funding_grant_id>81572777</funding_grant_id><funding_grant_id>CA016672</funding_grant_id><funding_grant_id>RP140462</funding_grant_id><funding_grant_id>R01 CA175486</funding_grant_id><funding_grant_id>CA168394</funding_grant_id><funding_grant_id>CA098258</funding_grant_id><funding_grant_id>U01 CA168394</funding_grant_id><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>R50 CA221675</funding_grant_id><funding_grant_id>U24 CA209851</funding_grant_id><funding_grant_id>RP130397</funding_grant_id><funding_grant_id>CA143883</funding_grant_id><funding_grant_id>1S10OD012304-01</funding_grant_id><funding_grant_id>U01 CA217842</funding_grant_id><funding_grant_id>U24 CA143883</funding_grant_id><funding_grant_id>RR150085</funding_grant_id><pubmed_authors>Peng X</pubmed_authors><pubmed_authors>Jeong KJ</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Han L</pubmed_authors><pubmed_authors>Labrie M</pubmed_authors><pubmed_authors>Tsang YH</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Mojumdar K</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Scott KL</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Hawke DH</pubmed_authors><pubmed_authors>Hwu P</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Mills GB</pubmed_authors></additional><is_claimable>false</is_claimable><name>A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.</name><description>Adenosine (A) to inosine (I) RNA editing introduces many nucleotide changes in cancer transcriptomes. However, due to the complexity of post-transcriptional regulation, the contribution of RNA editing to proteomic diversity in human cancers remains unclear. Here, we performed an integrated analysis of TCGA genomic data and CPTAC proteomic data. Despite limited site diversity, we demonstrate that A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences. We validate the presence of editing events at both RNA and protein levels. The edited COPA protein increases proliferation, migration, and invasion of cancer cells in vitro. Our study suggests an important contribution of A-to-I RNA editing to protein diversity in cancer and highlights it</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2026-05-02T02:27:13.647Z</modification><creation>2019-06-06T23:03:39Z</creation></dates><accession>S-EPMC5953833</accession><cross_references><pubmed>29706454</pubmed><doi>10.1016/j.ccell.2018.03.026</doi></cross_references></HashMap>